Valuation: Bayer AG

Market Cap 47.76B 55.78B 44.56B 40.89B 76.83B 5,337B 78.34B 529B 206B 2,675B 209B 205B 8,855B P/E 2026 *
20.8x
P/E 2027 * 15.6x
Enterprise Value 77.83B 90.91B 72.62B 66.64B 125B 8,698B 128B 862B 336B 4,359B 341B 334B 14,432B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.09%
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-20.81%0.00% - - 55.78B
-2.81%+2.93%+76.40%+127.73% 1,109B
-2.21%+2.02%+49.50%+55.01% 644B
-1.56%+4.39%+25.19%+74.39% 463B
-1.51%+3.27%+39.70%+44.20% 371B
-1.16%+2.04%+21.47%+38.82% 301B
-0.85%+4.54%-0.56%+12.24% 256B
-1.95%+3.80%+46.31%+65.66% 234B
-0.43%+0.10%-17.16%-53.22% 205B
-2.82%+3.84%+20.81%+89.04% 178B
Average -2.78%+3.00%+29.07%+50.43% 417.9B
Weighted average by Cap. -0.78%+3.26%+42.65%+69.95%

Financials

2026 *2027 *
Net sales 45.75B 53.43B 42.68B 39.17B 73.6B 5,113B 75.05B 506B 197B 2,562B 201B 196B 8,483B 46.97B 54.86B 43.82B 40.21B 75.56B 5,249B 77.05B 520B 203B 2,631B 206B 201B 8,709B
Net income 2.13B 2.49B 1.99B 1.83B 3.43B 238B 3.5B 23.6B 9.2B 119B 9.35B 9.15B 395B 2.95B 3.44B 2.75B 2.52B 4.74B 329B 4.84B 32.62B 12.72B 165B 12.93B 12.64B 547B
Net Debt 30.08B 35.13B 28.06B 25.75B 48.39B 3,361B 49.34B 333B 130B 1,685B 132B 129B 5,577B 26.9B 31.42B 25.1B 23.03B 43.27B 3,006B 44.13B 298B 116B 1,507B 118B 115B 4,988B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.61EUR
Average target price
56.83EUR
Spread / Average Target
+16.92%

Quarterly revenue - Rate of surprise